Skip to content

Icosapent ethyl

Vascepa, Vazkepa (icosapent ethyl) is a small molecule pharmaceutical. Icosapent ethyl was first approved as Vascepa on 2012-07-26. It has been approved in Europe to treat dyslipidemias. Vascepa's patents are valid until 2033-06-28 (FDA).
Trade Name Vazkepa
Common Name Icosapent ethyl
Indication dyslipidemias
Drug Class Antilipemic Agents
Icosapent ethyl
Get full access now